Tyler Dylan-Hyde, Chief Legal Officer at CRISPR Therapeutics AG (CRSP), sold 17,864 shares at $16.44 ($299K) on 2017-04-24, disclosed to the SEC on 2017-04-25.
Open-market sale of $299k CRSP by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.02 | 3,010 | $51K | 17.1% |
| 2 | $17.02 | 3,010 | $51K | 17.1% |
| 3 | $16.44 | 3,522 | $58K | 19.3% |
| 4 | $16.44 | 3,522 | $58K | 19.3% |
| 5 | $16.87 | 4,800 | $81K | 27.1% |
| Total | $16.75 avg | 17,864 |
| $299K |
| 100% |
| Filing → |
| CRSP | SELL | 2018-01-02 | $840K | — | Filing → |
| CRSP | SELL | 2017-12-27 | $308K | — | Filing → |
| CRSP | SELL | 2017-12-19 | $284K | — | Filing → |